DSV, 1022 - Annual General Meeting of DSV A/S 16 March 2023
Company Announcement No. 1022
The Annual General Meeting of DSV A/S was held today.
Agenda and resolutions
1. Report of the Board of Directors and the Executive Board on the activities of the Company in 2022
The report was not subject for voting. The Annual General Meeting took note of the report.
2. Presentation of the 2022 Annual Report with the audit report for adoption
The 2022 Annual Report was approved.
3. Resolution on application of profits or covering of losses as per the adopted 2022 Annual Report
The Board of Directors’ proposal for application of the profit of the year, including the proposal for a dividend of DKK 6.50 per share to be paid out, was approved.
4. Approval of the proposed remuneration of the Board of Directors for the current financial year
It was approved that the basic fee for remuneration of the Board of Directors will be DKK 600,000 in 2023.
5. Presentation and approval of the 2022 Remuneration Report
The 2022 Remuneration Report was approved.
6. Election of members for the Board of Directors
Thomas Plenborg, Jørgen Møller, Marie-Louise Aamund, Beat Walti, Niels Smedegaard, Tarek Sultan Al-Essa and Benedikte Leroy were re-elected as members of the Board, and Helle Østergaard Kristiansen was elected as a new member of the Board.
7. Election of auditor(s)
PricewaterhouseCoopers, Statsautoriseret Revisionspartnerselskab (CVR.no. 33 77 12 31) was re-elected as auditor of the Company.
8. Proposed resolutions
8.1 Authorisation to acquire treasury shares
The Board of Directors was granted authority to procure that the Company acquires treasury shares of a nominal value of up to DKK 21,900,000 during the next five years, corresponding to 10 per cent of the share capital provided that the Company's portfolio of treasury shares does not exceed 10 per cent of the Company’s share capital at any time.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration3.5.2024 07:57:38 CEST | Press release
For the first quarter as Novonesis, the company delivers 4% organic sales growth in line with expectations. Novonesis maintains the 2024 outlook of 5-7% organic sales growth with an adjusted EBITDA margin of around 35%. COPENHAGEN, Denmark – May 3, 2024. In the first three months of the 2024 financial year, Novonesis delivers 4% organic sales growth against a strong comparator. The organic sales growth in the first quarter is driven by both Food & Health Biosolutions and Planetary Health Biosolutions. Overall, volumes increased by around 2% and pricing contributed around 2%. “We are off to a good start. With 4% organic sales growth, we deliver in line with expectations for the first three months, and we continue to successfully move forward on the integration. Being in a place of comfort, we are already seeing synergies from bringing the two great legacy companies together, and we are fully focused on both short and long-term deliverables and developments. I am proud and thankful to se
Trading statement Q1 20243.5.2024 07:56:10 CEST | Press release
Novonesis realized 4% organic sales growth in line with expectations and maintains 2024 outlook. Ester Baiget, President & CEO: “I am pleased with the first quarter organic sales growth of 4% with growth in both Food & Health and Planetary Health. We are off to a good start in line with expectations and very well on track to deliver 5-7% organic sales growth for the full year with an adjusted EBITDA margin of around 35%. It’s highly comforting to see our new organization’s focus on both short and long-term deliverables and developments.” Pro forma sales performance¹ (organic sales growth calculation capped for hyperinflation countries) Against a strong comparable Novonesis realized 4% pro forma organic sales growth in Q1 2024. Volumes increased by around 2% and pricing also contributed around 2%. Pro forma sales in EUR amounted to 965.5 million, an increase of 1% (organic +4%, currency -2%, M&A -1%). Emerging markets grew 14% organically, while developed markets declined 1%. Food & Hea
Netcompany - Launch of share buyback programme3.5.2024 07:31:47 CEST | Press release
Company announcement No. 19/2024 3 May 2024 Launch of share buyback programme Today, Netcompany Group A/S (“Netcompany”) announces that the Board of Directors has decided to initiate a share buyback programme of up to DKK 250m for the purpose of meeting the future commitments under its LTIP programmes (RSU). The share buyback programme is launched with reference to the authorisation to acquire treasury shares granted by the general meeting on 2 March 2023. The authorisation is valid until 2 March 2028 and allows Netcompany to acquire shares with a total nominal value of up to 10% of its share capital. The share buyback programme will end no later than 12 August 2024. The share buyback programme will be executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Regulation”). Netcompany has appointed Nordea Danmark, Filial af Nordea Bank Abp, Fi
Selskabsmeddelelse – 1. kvartal 20243.5.2024 07:31:00 CEST | pressemeddelelse
Selskabsmeddelelse – 1. kvartal 2024 Administrerende direktør Kamilla Hammerich Skytte udtaler om 1. kvartal 2024: “Realkredit Danmark opnåede et stabilt resultat i 1. kvartal 2024 på 1.005 mio. kr. Den positive udvikling i toplinjen skyldtes det højere renteniveau. Periodens resultat faldt med 58 mio. kr. som følge af øgede modelbaserede nedskrivninger på udlån. Aktiviteten på boligmarkedet var som ventet lav i starten af året som følge af boligskattereformen, der betød, at en del bolighandler var blevet fremskyndet til slutningen af 2023. Der var dog en stigning i antallet af bolighandler hen mod slutningen af kvartalet. Forventningen til 2024 er, at vi generelt kommer til at se moderate stigninger i boligpriserne på landsplan. Pæne lønstigninger, og dermed en genvunden købekraft, vil sammen med lav ledighed og udsigt til fornuftig økonomisk aktivitet i samfundet have en positiv afsmitning på boligmarkedet. Omvendt er renteniveauet væsentligt højere end for få år siden, ligesom købek
Company announcement for the first quarter of 20243.5.2024 07:31:00 CEST | Press release
Company announcement for the first quarter of 2024 Kamilla Hammerich Skytte, CEO, comments on the first quarter of 2024: “In the first quarter of 2024, Realkredit Danmark recorded a stable result of DKK 1,005 million. The positive development in the top line was attributable to the rise in interest rate levels. Net profit for the period was down DKK 58 million because of an increase in model-based loan impairment charges. As expected, housing market activity was low early in the year as a consequence of the property tax reform, which meant that many housing trades had been brought forward to late 2023. Towards the end of the first quarter of 2024, however, we saw an increase in the number of housing trades. We expect to see moderate rises in general house prices across Denmark in 2024. A fair increase in salaries and the consequent recovery in consumer purchasing power combined with low unemployment and prospects of reasonable economic activity in society will have a positive effect on